Biotechnology The Most Important Catalyst For Merck’s Stock In 2024 Could Be Sotatercept Launch, Analyst Says – Merck & Co (NYSE:MRK) Read more
Biotechnology Merck Stock Soars On FDA Approval for Winrevair: Technical Analysis And Market Outlook – Merck & Co (NYSE:MRK) Read more
Biotechnology After Failed Prostate Cancer Study Merck’s Keytruda Combination Therapy Flunks In Late-Stage Lung Cancer Study – Merck & Co (NYSE:MRK) Read more
Biotechnology Merck Highlights Data From Multiple Phase 3 Trials For Its Investigational Pneumococcal Conjugate Vaccine – Merck & Co (NYSE:MRK) Read more
Biotechnology Newly Diagnosed Cervical Cancer Patients – Merck’s Blockbuster Drug Keytruda Plus Chemoradiotherapy Improves Overall Survival – Merck & Co (NYSE:MRK) Read more
Biotechnology What’s Going On With Moderna Stock On Monday? – Merck & Co (NYSE:MRK), Moderna (NASDAQ:MRNA) Read more
Biotechnology Promising HIV Treatment: Phase 2 Clinical Trial Success for Gilead’s and Merck’s Combo Therapy – Merck & Co (NYSE:MRK), Gilead Sciences (NASDAQ:GILD) Read more
Biotechnology Merck Posts Surprise Quarterly Profit Against An Expected Loss, Oncology And Vaccines Drive Growth – Merck & Co (NYSE:MRK) Read more
Biotechnology Merck’s Multi-Billion Cancer Drug Keytruda Improves Disease-Free Survival In Advanced Bladder Cancer After Surgery, Data Shows – Merck & Co (NYSE:MRK) Read more